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Abstract
Losses to follow-up (LTFU) remain an important programmatic challenge. While numerous
patient-level factors have been associated with LTFU, less is known about facility-level fac-
tors. Data from the East African International epidemiologic Databases to Evaluate AIDS
(EA-IeDEA) Consortium was used to identify facility-level factors associated with LTFU in
Kenya, Tanzania and Uganda. Patients were defined as LTFU if they had no visit within 12
months of the study endpoint for pre-ART patients or 6 months for patients on ART. Adjust-
ing for patient factors, shared frailty proportional hazard models were used to identify the
facility-level factors associated with LTFU for the pre- and post-ART periods. Data from
77,362 patients and 29 facilities were analyzed. Median age at enrolment was 36.0 years
(Interquartile Range: 30.1, 43.1), 63.9% were women and 58.3% initiated ART. Rates (95%
Confidence Interval) of LTFU were 25.1 (24.7–25.6) and 16.7 (16.3–17.2) per 100 person-
years in the pre-ART and post-ART periods, respectively. Facility-level factors associated
with increased LTFU included secondary-level care, HIV RNA PCR turnaround time >14
days, and no onsite availability of CD4 testing. Increased LTFU was also observed when no
nutritional supplements were provided (pre-ART only), when TB patients were treated within
the HIV program (pre-ART only), and when the facility was open4 mornings per week
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(ART only). Our findings suggest that facility-based strategies such as point of care labora-
tory testing and separate clinic spaces for TB patients may improve retention.
Introduction
The number of individuals accessing treatment for HIV has increased markedly over the last
decade, particularly in sub-Saharan Africa (SSA) [1,2]. This has resulted in significant
decreases in morbidity and in mortality of around 32% between 2005 and 2014 among people
living with HIV (PLHIV) in SSA [1, 2]. However, engagement along all stages of the HIV cas-
cade of care is needed in order to achieve and maintain viral suppression and prevent new
infections [3,4]. Disruptions in care may undermine any individual gains in clinical outcomes
[5] and the interruption of ART can lead to treatment failure, and associated drug resistance
with disease progression [6]. Indeed, studies of patients traced following loss to follow-up
(LTFU) have reported higher rates of mortality compared to those retained in care [7]. Identi-
fying the various patient and structural factors that can increase risk of loss to follow-up are
needed to inform strategies that promote retention in care.
Recently, the Joint United Nations Programme on HIV/AIDS (UNAIDS) have endorsed
new global fast-track targets: 90% of all PLHIV to be diagnosed and know their status, 90% of
all people diagnosed with HIV infection to receive ART, and 90% of those receiving ART to be
virally suppressed by 2020 [8]. Retention in care from enrolment through ART-initiation and
beyond is critical for achieving these targets. Unfortunately, LTFU in both the pre- and post-
ART periods remains a key challenge for HIV programs. It is estimated that in sub-Saharan
Africa, less than half of individuals are retained in pre-ART care [9] and median retention at 3
years on ART has been shown to be 65–70% [10].
Various patient factors have been associated with becoming LTFU which include demo-
graphic (e.g., gender, age) [11–13] and clinical or laboratory characteristics (e.g., stage of dis-
ease or CD4 count) [14] as well as socio-economic (e.g., transport costs and income) [13–15]
and social factors (e.g., marital status) [13, 15]. While some attention has been paid to explor-
ing the facility-level factors that can affect LTFU rates including where care is located (e.g.,
decentralized care), the type and model of care (e.g., hospital-based versus primary health cen-
tres), staffing characteristics, and the role of patient-provider relationships [5, 11, 12, 15], fur-
ther study is needed to identify strategies and interventions that could be adopted at the facility
or program level to improve retention in all stages of the HIV care cascade [5]. Using East Afri-
can International epidemiologic Databases to Evaluate AIDS (EA-IeDEA) data, the objective of
the present study was to explore facility-level factors that are associated with LTFU in the pre-
and post-ART periods among patients receiving HIV care in Kenya, Uganda and Tanzania.
Materials and Methods
Study population: East African International epidemiologic Databases to
Evaluate AIDS (EA-IeDEA)
This retrospective cohort study involved patient-level and facility-level data from 29 sites affili-
ated with the East Africa (EA)-IeDEA Consortium. EA-IeDEA is a cohort of patients from
HIV clinical care sites in Uganda, Kenya and Tanzania. Data are collected in the context of rou-
tine care at baseline and each follow-up visit, including socio-demographic data, the date of
starting ART, type of treatment initiated, and, where available, CD4 counts and HIV-1 plasma
RNA levels at baseline and during follow-up. All programs collect pre-ART data. Many
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programs may also collect contact information to facilitate patient tracing although not all pro-
grams trace patients who become LTFU. Tracing methods for missed visits vary between sites
and may include mobile phone calls, SMS reminders, and/or home visits. Some clinics also
involve volunteers from community-based organizations (CBO) to track patients.
This analysis was limited to all adult patients, 14 years of age or older who were enrolled in
a clinic associated with EA-IeDEA between May 2000 and May 2009. The exact date of data-
base closure differed by program and ranged from 31 March 2008 to 19 May 2009. We
excluded pregnant women from our analyses, mainly because of the variability in the frequency
of follow-up for pregnant women and their movement between antenatal care (ANC) and HIV
care which can affect retention. Indeed, previous studies have demonstrated higher rates of
LTFU among pregnant women compared to non-pregnant women and other populations [16–
18].
In Kenya, participating programs included the United States Agency for International
Development-Academic Model Providing Access to Healthcare (USAID-AMPATH), the Fam-
ily AIDS Care and Education Services (FACES), and the MTCT (Mother-to-Child Transmis-
sion)-Plus program in Kisumu. In Uganda, affiliated sites included the Infectious Diseases
Institute (IDI), Mbarara Immune Suppression Syndrome (ISS) clinic and the Makerere Univer-
sity-Johns Hopkins University (MU-JHU) collaboration at Mulago Hospital (MTCT-Plus pro-
gram). Contributing sites in Tanzania included the Tumbi Regional Hospital in Kibaha, the
Ocean Road Cancer Institute in Dar es Salaam, and the Morogoro Regional Hospital in Moro-
goro. Facility data came from a survey of all participating facilities conducted between August
2009 and February 2010 [19]. All analysis was performed with de-identified data and presented
at the country or program level. The IeDEA protocol was approved by the Indiana University
IRB and all local regulatory bodies involved in this consortium. Patient level consent was
waived by all regulatory entities because the data were de-identified prior to analysis and all
data were routinely collected as part of patient care.
Measures
A socio-ecological framework was developed to guide our hypotheses about what measures to
include in this analysis [20]. In this framework, the probability of becoming LTFU is a combi-
nation of individual patient factors (e.g., demographic, socio-economic and clinical characteris-
tics), healthcare facility factors (e.g., location, operations and strategies used for retention) and
broader contextual factors including the national context (e.g., policies, infrastructure, environ-
ment). Note, only patient-level and facility-level factors were available and explored in the
present study.
Loss to follow-up, the primary outcome, was defined as no clinic visits for at least 12 months
for the pre-ART period and at least 6 months for the post-ART period, immediately prior to
database closure. Six months has previously been proposed as the most informative definition
of LTFU for individuals on ART [21]. For individuals not yet on ART, routine follow-up may
be less frequent (e.g., 3 to 6 months) suggesting that such individuals would be considered
LTFU if they missed two to four visits.
Patient-level measures included demographic factors: age at enrolment (in years) and gen-
der (male/female); socio-economic characteristics: education level (none, some primary, some
secondary, some college/university/technical), disclosure of HIV status (yes/no), and travel
time to clinic (<30 minutes, 30–60 minutes, 1–2 hours,>2 hours); and clinical characteristics:
on ART (yes/no), time on ART (in months), CD4 count at enrolment (cells/μl), CD4 count at
ART initiation (<201, 201–350, 351–500, 501–650,>650), World Health Organization
(WHO) clinical stage at enrolment (pre-ART analysis) and/or at ART initiation (ART analysis)
Facility-Level Factors Influencing Retention in HIV Care
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(Stage 1–4), ever on TB treatment (yes/no) and calendar year at enrollment or ART initiation
(2000–2006; 2007–2009). Two periods were selected to account for the rapid expansion of
highly active antiretroviral therapy in East Africa.
Since little is known about how facility factors can influence retention in HIV care, we
explored a range of available facility-level characteristics. We used our conceptual model to cat-
egorize facility factors of interest. General facility characteristics included location (urban,
rural, semi-urban), HIV lab availability including HIV RNA PCR (on site vs. off site vs. not
available) and CD4 count (on site vs. off site) as well as the turnaround time for HIV RNA
PCR (14 days vs.>14 days) and CD4 count (7 days vs.>7 days). Availability of non- HIV
labs (on site vs. off site) which included total lymphocytes, ALT/AST, and creatinine were also
recorded as well as disruptions in CD4 reagents in the last year (no vs. yes). The level of care
including whether the facility was considered primary (e.g., community health centres, dispen-
saries), secondary (e.g., district hospitals) or tertiary (e.g., regional hospitals, referral hospitals)
was also explored. Clinical operations included operating hours: open4 mornings vs.>4
mornings during the week, open 4 evenings vs.>4 evenings during the week, and open on
weekends (no vs. yes); presence of an electronic database to capture data on patients who trans-
fer in (no vs. yes) and transfer out (no vs. yes); a waitlist for initiating ART (no vs. yes); daily
average number of available physicians/mid-level staff (<3 vs.3); ratio of adult patients to
daily number of physicians/mid-level staff (<10 vs.10); daily average number of lay outreach
workers (<2 vs.2); the ratio of adult patients to number of lay outreach workers (<10 vs.
10); whether cotrimoxazole prophylaxis, food rations/supplements, vitamins (including
zinc), and nutritional treatment is provided (no vs. yes) and whether TB is diagnosed and
treated within the ART program (yes vs. symptomatic patients referred to TB clinic). Retention
strategies included whether pre-ART outreach services were available (no vs. yes), the number
of days to track patients after a missed visit (7 days vs.>7 days), whether outreach workers
phone missing patients first (no vs. yes), if a business number (no vs. yes) or a relative’s number
(no vs. yes) was available, availability of home visits (no vs. yes), type of transport for home vis-
its (all available vs. bike/foot/public vs. motor vehicle only) and death ascertainment through
active outreach (no vs. yes). While broader national contextual factors also influence LTFU, we
were unable to measure such factors directly.
Statistical analysis
Categorical variables were described using frequencies and proportions. Description of the
quantitative variables was based on the median and interquartile range (IQR). Rates of LTFU
were estimated using the maximum likelihood under an exponential distribution assumption,
and the associated standard errors were calculated based on non-parametric bootstrap meth-
odology. Modelling the cause-specific hazard of LTFU was based on the semi-parametric pro-
portional hazards model, with a gamma-distributed shared frailty according to EA-IeDEA
program to take into account the association between patients from the same EA-IeDEA pro-
gram. Pre-ART and post-ART periods were analysed separately (S1 File). Note that an interac-
tion term for use of vitamin and nutritional supplements was also explored. The time origin for
the pre-ART analysis was enrolment date whereas ART initiation date was used for the post-
ART analysis. Follow-up was right-censored at ART initiation or database closure date (which-
ever came first) for the pre-ART analysis and database closure date for the post-ART analysis.
Death (for both analyses) and ART initiation (for pre-ART analysis) were considered as com-
peting risks to LTFU. Variable selection was performed in two phases: First patient-level vari-
ables were selected using a backwards elimination procedure (while keeping in the model age
and gender regardless of the significance level) and second, conditional on the selected patient-
Facility-Level Factors Influencing Retention in HIV Care
PLOS ONE | DOI:10.1371/journal.pone.0159994 August 10, 2016 4 / 16
level variables, the facility-level variables were selected again using backwards variable elimina-
tion procedure.
The date of death was missing for 718 (13.7%) of the 5,256 deaths that occurred in this sam-
ple. In order to deal with missing death times, we performed hot-deck imputation [22] under
the assumption of missing at random (MAR). In this method, each patient with a missing
death date is associated with a set of similar patients with known death dates (donor pool). The
key advantage of this method is that it is non-parametric, which means that it does not make
any distributional assumptions about the missing data. To make the MAR assumption plausi-
ble, we evaluated factors affecting both the probability of missingness in the date of death and
also the death time. The covariates used to form the donor pools for imputing the missing
death times (recipient pool) were age category at last clinic visit, gender, CD4 cell count at
enrolment, WHO stage at enrolment and the indicator of being on ART at the last clinic visit.
In cases with missing CD4 or WHO stage, those variables were not used in creating donor
pools. Standard error (SE) estimation was based on non-parametric bootstrap SE estimator (20
replications), taking into account the additional source of uncertainty due to imputing the
missing death times [22]. Since the sample size was large, standard asymptotic distribution
results were used for 95% confidence intervals (CI) and p-value calculations. Statistical analysis
was performed using the Stata 13 for Windows statistical package.
Results
In total, the analysis included 88,152 patients enrolled in one of the 29 clinics from 9 programs
within the EA-IeDEA Consortium. The majority were female (68.3%) and 10,790 (18.0%)
women were pregnant at some point during the follow-up period. After excluding pregnant
women, the final sample size consisted of 77,362 patients.
Patient and facility-level characteristics
Demographic and clinical characteristics of the study sample are presented in Table 1. Briefly,
the overall median (IQR) age at enrolment was 36.0 (30.1, 43.1). More than half of the patients
(58.3%) initiated ART at some point during their follow-up. Median CD4 levels around ART
initiation were similar for the three countries (median range: 105–109 cells/μl).
A description of the key facility-level characteristics is given in Table 2. Only a small fraction
of the clinics were located in rural areas (13.8%) and a minority provided tertiary level of care
(20.7%). While more than half of the clinics were open more than four mornings and more
than four evenings during the week, the majority (96.6%) were not open on the weekends.
Most of the clinics did not have a wait list for initiating ART (75.9%). The majority of clinics
provided nutritional supplements (79.3%) and food rations (75.9%). Only a minority of facili-
ties had on-site HIV RNA PCR (17.2%) and CD4 count (31.0%) testing, and turnaround time
for HIV RNA PCR results was>14 days for the majority of clinics. The vast majority of sites
had at least two outreach workers (82.8%) and outreach efforts were initiated within a week
after a missed clinic visit in most cases (79.3%). The ratio of adult patients to the number of
outreach workers was at least 10 to 1 in 75.9% of clinics. Death was ascertained through active
outreach methods in the majority of sites (82.8%).
Frequency and predictors of LTFU
Pre-ART and post-ART rates of LTFU by EA-IeDEA program are presented in Fig 1. The over-
all rates (95% Confidence Intervals (CI)) of LTFU were 25.1 (24.7–25.6) and 16.7 (16.3–17.2)
per 100 person-years in the pre-ART and post-ART analysis, respectively. Programs from Tan-
zania reported the highest rates of LTFU (95% CI): 62.3 (57.9–67.2) and 53.2 (50.4–56.0) for
Facility-Level Factors Influencing Retention in HIV Care
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Table 1. Patient characteristics of included patients at all EA-IeDEA sites.
East Africa IeDEA Country
Kenya Tanzania Uganda Overall
N (%) N (%) N (%) N (%)
Gender
Female 38178 (63.9) 5402 (67.7) 5733 (59.5) 49313 (63.7)
Male 21354 (35.7) 2575 (32.3) 3910 (40.5) 27839 (36.0)
Missing 210 (0.4) 0 (0.0) 0 (0.0) 210 (0.3)
HIV status disclosed
No 18646 (31.2) 0 (0.0) 153 (1.6) 18799 (24.3)
Yes 33296 (55.7) 0 (0.0) 616 (6.4) 33912 (43.8)
Missing 7800 (13.1) 7977 (100.0) 8874 (92.0) 24651 (31.9)
Highest education level achieved
None 1388 (2.3) 0 (0.0) 205 (2.1) 1593 (2.1)
Some primary 29954 (50.1) 0 (0.0) 829 (8.6) 30783 (39.8)
Some secondary 15997 (26.8) 0 (0.0) 418 (4.3) 16415 (21.2)
Some College/University or technical 3164 (5.3) 0 (0.0) 178 (1.8) 3342 (4.3)
Missing 9239 (15.5) 7977 (100.0) 8013 (83.1) 25229 (32.6)
Travel time to clinic
< 30 minutes 14566 (24.4) 0 (0) 205 (2.1) 14771 (19.1)
30–60 minutes 16983 (28.4) 0 (0) 459 (4.8) 17442 (22.5)
1–2 hours 12918 (21.6) 0 (0) 258 (2.7) 13176 (17.0)
> 2 hours 9165 (15.3) 0 (0) 186 (1.9) 9351 (12.1)
Missing 6110 (10.2) 7977 (100.0) 8535 (88.5) 22622 (29.2)
Ever on ART 31361 (52.5) 4281 (53.7) 9441 (97.9) 45083 (58.3)
CD4 at ART start (90 days pre—7 post) cells/μl
<201 19040 (60.7) 2537 (59.2) 4586 (48.6) 26163 (58.0)
201–350 3213 (10.2) 427 (10.0) 697 (7.4) 4337 (9.6)
351–500 770 (2.5) 103 (2.4) 81 (0.9) 954 (2.1)
501–650 345 (1.1) 32 (0.7) 45 (0.5) 422 (0.9)
>650 329 (1.0) 15 (0.3) 29 (0.3) 373 (0.8)
Missing 7664 (24.4) 1175 (27.4) 4003 (42.4) 12842 (28.5)
WHO stage at ART start (90 days pre—7 post)
1 4897 (18.8) 121 (4.8) 307 (3.7) 5325 (14.4)
2 5395 (20.7) 664 (26.3) 2374 (28.5) 8433 (22.8)
3 13046 (50.0) 980 (38.8) 3408 (40.9) 17434 (47.2)
4 2747 (10.5) 764 (30.2) 2238 (26.9) 5749 (15.6)
TB treatment (at any time) 13218 (22.1) 556 (7.0) 3059 (31.7) 16833 (21.8)
Median (IQR) Median (IQR) Median (IQR) Median (IQR)
Age at enrollment (years) 35.9 (29.9, 43.2) 36.6 (30.6, 44.0) 36.0 (30.7, 41.7) 36.0 (30.1, 43.1)
CD4 at enrollment (w/in 3 mos) cells/μl 198 (80, 381) 151 (60, 306) 131 (45, 245) 185 (74, 359)
CD4 at ART start (90 days pre—7 post) cells/μl 109 (45, 183) 105 (39, 178) 107 (36, 176) 109 (43, 181)
Median* (95% CI) Median* (95% CI) Median* (95% CI) Median* (95% CI)
Pre-ART follow up duration (years) 0.34 (0.33, 0.35) 0.20 (0.19. 0.21) 0.32 (0.31, 0.33) 0.32 (0.31, 0.33)
ART follow up duration (years) 1.57 (1.56. 1.59) 1.26 (1.20, 1.32) 2.68 (2.53, 2.82) 1.66 (1.64, 1.68)
* Calculated using the Kaplan-Meier estimator by considering right censoring as the event of interest.
doi:10.1371/journal.pone.0159994.t001
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Table 2. Facility-level characteristics of included facilities (n = 29).
GENERAL FACILITY CHARACTERISTICS n (%)
Location
Urban 12 (41.4)
Rural 4 (13.8)
Semi-urban 13 (44.8)
Level of care
Primary 10 (34.5)
Secondary 13 (44.8)
Tertiary 6 (20.7)
HIV RNA PCR: Availability
On Site 5 (17.2)
Off Site 22 (75.9)
Test Not Available 2 (6.9)
HIV RNA PCR turnaround time
< = 14 days 9 (31.0)
>14 days 17 (58.6)
Unknown/missing 3 (10.3)
CD4 count: Availability
On Site 9 (31.0)
Off Site 20 (69.0)
CD4 turnaround time
< = 7 days 14 (48.3)
>7 days 15 (51.7)
Disruption in CD4 reagents in last year
Yes 8 (27.6)
No 21 (72.4)
Non-HIV labs*
On Site 10 (34.5)
Off Site 19 (65.5)
CLINICAL OPERATIONS
Open in mornings
< = 4 mornings 11 (37.9)
>4 mornings 18 (62.1)
Open in evenings
< = 4 evenings 13 (44.8)
>4 evenings 16 (55.2)
Open on weekends
No 28 (96.6)
Yes 1 (3.4)
Waiting list for initiating ART
Yes 7 (24.1)
No 22 (75.9)
Electronic Database to capture patients transferred in
No 20 (69.0)
Yes 9 (31.0)
Electronic database to capture patients transferred out
Yes 24 (82.8)
Not applicable 5 (17.2)
(Continued)
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Table 2. (Continued)
GENERAL FACILITY CHARACTERISTICS n (%)
Daily average number of physicians/mid-level staff
<3 11 (37.9)
 3 18 (62.1)
Ratio of adult patients to physicians/mid-level staff
<10 8 (27.6)
10 21 (72.4)
Daily average number of lay outreach workers
<2 5 (17.2)
2 24 (82.8)
Ratio of adult patients to lay outreach workers
<10 7 (24.1)
10 22 (75.9)
Vitamins (including ZINC) provided
No 20 (69.0)
Yes 9 (31.0)
Nutritional supplements
No 6 (20.7)
Yes 23 (79.3)
Food rations
No 7 (24.1)
Yes 22 (75.9)
Cotrimoxazole prophylaxis prescribed
No 22 (75.9)
Yes 7 (24.1)
TB diagnosed and treated within ART program
Yes, at ART initiation and regularly thereafter 19 (65.5)
No, symptomatic patients are referred to the TB clinic 10 (34.5)
RETENTION STRATEGIES
Pre-ART outreach program
No 15 (51.7)
Yes 14 (48.3)
days to track patient after missed visit
>7 6 (20.7)
< = 7 23 (79.3)
Phone first for outreach
No 3 (10.3)
Yes 26 (89.7)
Business number available
No 12 (41.4)
Yes 17 (58.6)
Relative number available
No 8 (27.6)
Yes 21 (72.4)
Home visits available
No 2 (6.9)
Yes 27 (93.1)
Type of transport for home visits
(Continued)
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the pre-ART and post-ART analysis, respectively. LTFU was lowest in Ugandan programs par-
ticularly in the pre-ART period: 0.6 (0.5–0.7) and 11.9 (11.4–12.6). The corresponding figures
for Kenya were 27.0 (26.4–27.7) per 100 person-years in the pre-ART period and 15.9 (15.3–
16.4) in the ART period. Additionally, significant variability was observed regarding rates of
LTFU among EA-IeDEA programs within the same country.
Results from the multivariable analysis of LTFU both pre- and post-ART initiation are pre-
sented in Table 3. Secondary-level care was associated with a decreased hazard of LTFU both
pre-ART and post-ART (adjusted hazard ratios- AHRs (95% CI): 0.81 (0.75–0.88) and 0.76
(0.71–0.81), respectively). Nutritional supplements (0.62, 0.44–0.87) and referring TB patients
to a separate TB clinic (versus treating them within the ART program) (0.91, 0.83–0.99) both
had favourable impacts on LTFU in the pre-ART period only. Rates of LTFU were higher in
facilities without CD4 tests available on-site and with longer HIV-RNA PCR turnaround
times, in both analysis periods (pre-ART 1.21 (1.11–1.33) and 1.14 (1.07–1.20), respectively;
post-ART: 1.19 (1.05–1.34) and 1.29 (1.19–1.40), respectively). Being open more than 4
Table 2. (Continued)
GENERAL FACILITY CHARACTERISTICS n (%)
All available 22 (78.6)
Bike/Foot/Pub 3 (10.7)
Car only 2 (7.1)
N/A 1 (3.6)
Death ascertained through active outreach
No 5 (17.2)
Yes 24 (82.8)
* Non-HIV labs include total lymphocytes, total ALT/AST and creatinine.
doi:10.1371/journal.pone.0159994.t002
Fig 1. Rates of loss to follow up (LTFU) by country and EA-IeDEA program.
doi:10.1371/journal.pone.0159994.g001
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Table 3. Factors associated with cause-specific hazard of loss to follow-up from enrollment (Pre-ART) and after ART initiation in multivariate anal-
ysis.**
Pre-ART (n = 58,727) ART (n = 35,041)
HR 95% CI p-value HR 95% CI p-value
Level of care
Primary 1 1
Secondary 0.81 (0.75, 0.88) <0.001 0.76 (0.71, 0.81) <0.001
Tertiary 0.938 (0.79, 1.09) 0.36 1.32 (1.10, 1.58) 0.002
Nutritional supplements
No 1 1
Yes 0.62 (0.44, 0.87) 0.006 1.22 (0.71, 2.09) 0.480
HIV RNA PCR turnaround time
< = 14 days 1 1
>14 days 1.14 (1.07, 1.20) <0.001 1.29 (1.19, 1.40) <0.001
Unknown/missing 1.47 (1.10, 1.95) 0.008 2.64 (2.01, 3.45) <0.001
CD4 count: Availability
On Site 1 1
Off Site 1.21 (1.11, 1.33) <0.001 1.19 (1.05, 1.34) 0.005
Identify pts transferred in (electronic database)
No 1
Yes 1.36 (0.88, 2.12) 0.171 - - -
Have waiting list for initiating ART for adult patients followed at this facility
Yes 1 1
No 0.99 (0.70, 1.41) 0.97 0.90 (0.57, 1.40) 0.631
TB diagnosed and treated by clinicians within the ART program
Yes, at ART initiation and regularly thereafter 1 1
No, symptomatic patients are referred to the TB clinic 0.91 (0.83, 0.99) 0.044 0.91 (0.79, 1.05) 0.181
Open in mornings
< = 4 mornings 1
>4 mornings - - - 0.75 (0.62, 0.90) 0.003
Open in evenings
< = 4 evenings 1 1
>4 evenings 0.92 (0.85, 1.00) 0.054 1.21 (0.98, 1.49) 0.083
Phone first for outreach
No 1
Yes - - - 0.85 (0.59, 1.22) 0.377
Male gender
No 1 1
Yes 1.07 (1.03, 1.12) 0.002 1.04 (0.98, 1.09) 0.164
Age at enrollment
<25 1 1
25–34.9 0.68 (0.63, 0.73) <0.001 0.70 (0.63, 0.78) <0.001
35–44.9 0.50 (0.47, 0.52) <0.001 0.57 (0.51, 0.63) <0.001
45+ 0.47 (0.44, 0.50) <0.001 0.56 (0.50, 0.63) <0.001
WHO stage at enrollment (w/in 3 mos)
1 1 1
2 1.01 (0.94, 1.08) 0.844 0.99 (0.92, 1.07) 0.836
3 1.14 (1.08, 1.21) <0.001 1.16 (1.08, 1.24) <0.001
4 1.61 (1.46, 1.78) <0.001 1.64 (1.53, 1.76) <0.001
(Continued)
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mornings per week was associated with a decreased hazard of LTFU (0.75, 0.62–0.90) in the
ART period.
While this analysis focused primarily on facility-level factors, various patient-level factors
were also significant, and include younger age, more advanced HIV disease based on WHO
stage, and lower educational level were all associated with increased hazards of LTFU. LTFU in
the pre-ART follow-up period was more frequent among men and patients enrolled prior to
2007. Conversely, LTFU was slightly higher in the post-ART period among those initiating
ART more recently (2007–2009 vs. 2000–2006). Tertiary care, the ability to identify patients
who transferred in (electronic database), and having a waiting list for initiating ART were not
significantly associated with LTFU in the pre-ART period. The provision of nutritional supple-
ments, having a waiting list for initiating ART, referring TB symptomatic patients to a TB
clinic, phone first for outreach, and being male were not significantly associated with LTFU
from ART.
Discussion and Conclusions
In this comprehensive analysis of facility-level factors associated with LTFU in 77,362 patients
from 29 facilities across three east African countries, we found numerous facility-level factors
that were associated with reduced LTFU: facility open more than 4 mornings per week; provi-
sion of care at secondary-level facilities such as district hospitals compared to primary care
facilities; provision of nutritional supplements, provision of onsite laboratory services and
faster CD4 results; and provision of TB care separate from HIV and ART care. These findings
suggest some specific modifiable facility-level strategies that programs and facilities should
consider when planning and implementing their services to promote retention in HIV care
and in turn, maintenance of viral suppression. We found that LTFU rates were also higher in
the pre-ART period compared to the ART period, although this is likely to reduce with pro-
gressive adoption and implementation of a “treat all” strategy as recommended by WHO, min-
imising time between diagnosis and ART initiation [23].
LTFU rates were lower in secondary-level facilities compared to primary care facilities.
Other studies have shown that decentralization is associated with improved retention [12, 24],
as care that is located closer to the home may result in improved geographical access and
decreased transport costs. However, the level of care (tertiary, secondary or primary care) is
also be a proxy for other factors including staffing, available resources and services provided. A
Table 3. (Continued)
Pre-ART (n = 58,727) ART (n = 35,041)
HR 95% CI p-value HR 95% CI p-value
Calendar year*
2000–06 1 1
2007–09 0.34 (0.31, 0.36) <0.001 1.07 (1.02, 1.12) 0.009
Highest education level achieved
None 1 1
Some primary 0.82 (0.71, 0.94) 0.004 0.84 (0.76, 0.93) 0.001
Some secondary 0.70 (0.62, 0.80) <0.001 0.75 (0.67, 0.85) <0.001
Some College/University or technical 0.67 (0.60, 0.76) <0.001 0.68 (0.59, 0.79) <0.001
Missing or N/A 0.79 (0.68, 0.91) 0.001 0.780 (0.70, 0.87) <0.001
*At enrollment or ART initiation
** Results from a multivariable semiparametric proportional hazards model with a gamma-distributed shared frailty according to EA-IeDEA program.
doi:10.1371/journal.pone.0159994.t003
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recent study on patient attitudes towards decentralization suggests that many patients experi-
ence less stigma in centralized sites where there is less proximity to their local community and
there are also a greater availability of services [25]. We found that provision of additional ser-
vices, including nutritional support (in pre-ART care only) and laboratory capacity (both pre-
and post-ART care) impacted LTFU. While not assessed directly in our study, our findings of
higher rates of LTFU among ART patients in tertiary care may be partially be explained by the
tendency to refer sicker patients to larger more specialized tertiary facilities which are usually
located in larger urban centers and farther from patients’ homes [26]. However, while some
individuals may prefer services closer to their homes to minimize travelling, others may pur-
posely avoid clinics close to their homes in order to conceal their status from community mem-
bers [27].
Facilities that were open more than 4 mornings per week reported fewer losses to follow-up.
More available and flexible opening hours [24, 27] may help particularly patients in full time
employment keep their clinic appointments, although health care worker shortages may make
this difficult to implement. This can be facilitated by task-shifting from clinicians to lower cad-
res of health workers to increase access [28] together with other strategies such as convenient
clinic location and ease of access. The promotion of differentiated care and follow up [29] with
less frequent visits for individuals stable and virally suppressed on ART represents a more effi-
cient and cost-effective service provision strategy [30], which minimises the onus on those who
have challenges attending the facility during current operating hours.
Provision of onsite laboratory services and faster results turnaround time was associated
with reduced LTFU. Our finding largely relates to delays in CD4 testing rather than viral load
(as few sites were undertaking routine viral load during the study period), and also may serve
as a proxy for facility function and responsiveness. It is recognized that limited human
resources, lack of timely CD4 testing (due to broken CD4 machines or missing reagents) [31]
and long delays in receiving results can decrease prompt assessment of ART eligibility and ini-
tiation [31] and negatively impact retention [15]. With the progressive shift towards imple-
mentation of a “treat all” strategy that does not require a CD4 cell count for ART initiation
[23], the impact of laboratory access is likely to lessen. Point of care CD4 testing has also been
used in many settings to reduce delays in receiving test results and ART initiation [31] as well
as improve linkage into care [27]. As viral load monitoring replaces CD4 cell count monitoring
as the main approach to assessment of ART response and diagnosis of treatment failure [32],
there will need to be an emphasis on reducing turnaround time and improving timely commu-
nication of results to patients in order to improve overall retention along the HIV cascade.
Finally, our study found that management of TB within the HIV and ART program rather
than in a separate TB programme was associated with a higher hazard of LTFU. HIV-TB co-
infection remains a major problem in sub-Saharan Africa and continues to present numerous
challenges to HIV treatment programs, particularly in infection control and risks of TB trans-
mission and acquisition in an HIV infected population [25]. In response, there has been a push
towards integrated care for HIV and TB [33] (e.g., providing services at single facility) which is
associated with increased uptake of HIV testing and TB case detection and also minimises
inconvenience of traveling to more than one facility and transport costs [34]. However, inte-
grating care presents several challenges: it may overburden already constrained HIV programs,
particularly given the more frequent clinic visits required during TB treatment [35]; increase
patient wait times, and present risks in infection control and nosocomial spread of TB to HIV
positive patients [34]. In addition, the number of staff trained in HIV-TB co-management may
be few and cross-training and the merging of operations may be costly [35]. A recent Ghanaian
study noted that while HIV testing increased among TB patients, ART use did not [36] and
more losses occurred in an integrated care program versus single service clinics in a South
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African study [37]. Further studies are needed to explore all aspects of the impact of integrated
care on retention [7, 24].
There were several limitations to the present study. The facility-level data available were
based on a site assessment that was conducted in late 2009 while the patient-level data was col-
lected from 2000 through early 2009. However, we consider that the critical patient and service
delivery factors still apply, and an updated assessment is planned to identify the impact of
more recent changes in facility-level factors on retention. There were also several potentially
important factors reported in other studies that we did not capture—these include the impact
of patient-provider relationships, clinic visit wait times, and transport costs to the clinic [5, 13–
15, 24], as well as significant missing data and lack of pre-ART data for one of the Uganda
sites. We were not able to exclude impact of potential bias by indication on our findings. For
example, it is also possible that our finding of a higher loss to follow up in primary care out-
reach programs, may have been because the outreach program itself was established as a result
of high rates of LTFU. While adjustment for time-dependent factors can help to minimize bias
[38], time-updated variables were not available in the present study. Finally, individuals not
tracked through outreach may have died and so we may have overestimated LTFU. There is a
clear need to distinguish patients who have died from those LTFU for other reasons in order to
more accurately estimate retention. This was a large analysis of more than 70,000 patients from
29 sites across three countries in east Africa, and although not based on comprehensive
national data, our study population was broadly representative of HIV infected patients’ popu-
lation of east Africa, with the exclusion of pregnant women and children under the age of 14
years.
Overall our findings support the implementation of several key strategies to improve reten-
tion in care: onsite and timely laboratory testing; flexible facility hours and daily clinics, provi-
sion of care in secondary level health facilities that can provide a more comprehensive range of
services. This will become more critical with continued scale up of ART to all 34 million per-
sons living with HIV. This is particularly the case in light of the increasing burden of co-mor-
bidities, such as tuberculosis, diabetes, or hypertension, and given the move towards more
comprehensive reproductive health care to prevent maternal-child HIV transmission. If we are
to meet the UNAIDS 2020 targets and fully realize the individual and public health benefits of
ART, health care facilities must be both evidence-based and patient –centered, along each stage
of the care-prevention continuum.
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